Myrtelle Canavan
.jpg)
Myrtelle Canavan (June 24, 1879 – August 4, 1953) was an American physician and pathologist known for her contributions to the field of neuropathology. She is best known for her discovery of Canavan disease, a rare genetic disorder that affects the central nervous system.
Early Life and Education[edit | edit source]
Myrtelle Canavan was born in Greenfield, Massachusetts. She attended Smith College, where she earned her undergraduate degree in 1900. She then went on to study at the Boston University School of Medicine, receiving her medical degree in 1905.
Career[edit | edit source]
After completing her medical education, Canavan worked at several institutions, including the Massachusetts State Hospital and the Boston Psychopathic Hospital. She became a prominent figure in the field of neuropathology, focusing on the study of brain diseases.
[edit | edit source]
In 1931, Canavan described a new form of leukodystrophy, which later became known as Canavan disease. This disorder is characterized by the degeneration of the white matter in the brain, leading to severe neurological impairment. Her work laid the foundation for further research into the genetic and biochemical aspects of the disease.
Contributions to Neuropathology[edit | edit source]
Canavan's research extended beyond Canavan disease. She made significant contributions to the understanding of various neurological disorders, including multiple sclerosis and Alzheimer's disease. Her work helped to advance the field of neuropathology and improve diagnostic techniques.
Legacy[edit | edit source]
Myrtelle Canavan's pioneering work in neuropathology has had a lasting impact on the field. Her discovery of Canavan disease has led to increased awareness and research into genetic disorders affecting the nervous system. She is remembered as a trailblazer for women in medicine and a dedicated scientist.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
